These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32624523)
1. Evaluation of a Synergistic Effect of L-Arginine on the Anticancer Activity of Doxorubicin by Using a Co-culture System. Feng H; Kishimura A; Mori T; Katayama Y Anal Sci; 2020 Oct; 36(10):1279-1283. PubMed ID: 32624523 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle. He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653 [TBL] [Abstract][Full Text] [Related]
4. Preparation of a PEGylated liposome that co-encapsulates l-arginine and doxorubicin to achieve a synergistic anticancer effect. Feng H; Kang JH; Qi S; Kishimura A; Mori T; Katayama Y RSC Adv; 2021 Oct; 11(54):34101-34106. PubMed ID: 35497323 [TBL] [Abstract][Full Text] [Related]
6. A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles. Kudo S; Nagasaki Y J Control Release; 2015 Nov; 217():256-62. PubMed ID: 26386436 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect. Song Y; Tang C; Yin C Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548 [TBL] [Abstract][Full Text] [Related]
8. L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro. Muijsers RB; ten Hacken NH; Van Ark I; Folkerts G; Nijkamp FP; Postma DS Eur Respir J; 2001 Oct; 18(4):667-71. PubMed ID: 11716172 [TBL] [Abstract][Full Text] [Related]
9. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics. Deng Y; Zhang H Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895 [TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer. Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide. Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106 [TBL] [Abstract][Full Text] [Related]
12. Seleno-l-methionine and l-ascorbic acid differentiate the biological activity of doxorubicin and its metal complexes as a new anticancer drugs candidate. Matejczyk M; Świderski G; Świsłocka R; Rosochacki SJ; Lewandowski W J Trace Elem Med Biol; 2018 Jul; 48():141-148. PubMed ID: 29773172 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin Intracellular Release El Founi M; Laroui H; Canup BSB; Ametepe JS; Vanderesse R; Acherar S; Babin J; Ferji K; Chevalot I; Six JL ACS Appl Bio Mater; 2021 Mar; 4(3):2742-2751. PubMed ID: 35014313 [TBL] [Abstract][Full Text] [Related]
14. Poly-L-arginine: Enhancing Cytotoxicity and Cellular Uptake of Doxorubicin and Necrotic Cell Death. Movafegh B; Jalal R; Mohammadi Z; Aldaghi SA Anticancer Agents Med Chem; 2018; 18(10):1448-1456. PubMed ID: 29651964 [TBL] [Abstract][Full Text] [Related]
15. Supramolecular Chiral Binding Affinity-Achieved Efficient Synergistic Cancer Therapy. Zhou J; Gu J; Sun X; Ye Q; Wu X; Xi J; Han J; Liu Y Adv Sci (Weinh); 2024 Apr; 11(16):e2308493. PubMed ID: 38380492 [TBL] [Abstract][Full Text] [Related]
16. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688 [TBL] [Abstract][Full Text] [Related]
17. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy. Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437 [TBL] [Abstract][Full Text] [Related]
18. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy. Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039 [TBL] [Abstract][Full Text] [Related]
19. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]